-
3HOI-BA-01
- names:
(E)-3-(4-(benzo[d][1,3]dioxol-5-yl)-2-oxobut-3-en-1-yl)-3-hydroxyindolin-2-one
- CAS号:
355428-84-1
MDL Number: - MF(分子式): C19H15NO5 MW(分子量): 337.33
- EINECS: Reaxys Number:
- Pubchem ID: Brand:BIOFOUNT
| 货品编码 | 规格 | 纯度 | 价格 (¥) | 现价(¥) | 特价(¥) | 库存描述 | 数量 | 总计 (¥) |
|---|
| 中文别名 | 3HOI-BA-01 |
| 英文别名 | 3HOI-BA-01; 3HOI BA 01; 3HOIBA01; 3-HOI-BA-01; |
| CAS号 | 355428-84-1 |
| Inchi | InChI=1S/C19H15NO5/c21-13(7-5-12-6-8-16-17(9-12)25-11-24-16)10-19(23)14-3-1-2-4-15(14)20-18(19)22/h1-9,23H,10-11H2,(H,20,22)/b7-5+ |
| InchiKey | AJJYRWYJJMMKIT-FNORWQNLSA-N |
| 分子式 Formula | C19H15NO5 |
| 分子量 Molecular Weight | 337.33 |
| 溶解度Solubility | |
| 性状 | Solid powder |
| 储藏条件 Storage conditions | Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years). |
| 产品说明 | 3HOI-BA-01(CAS:355428-84-1):仅限应用于工业或者科学研究过程中非医疗目的,不应用于人类或动物的临床诊断以及治过程疗,该产品非药用,非食用。 |
| Introduction | 3HOI-BA-01 is a mammalian targeting potent inhibitor of rapamycin (mTOR) activation. |
| Application1 | |
| Application2 | |
| Application3 |
| [1]Huang L, Dai K, Chen M, Zhou W, Wang X, Chen J, Zhou W. The AMPK Agonist PT1 and mTOR Inhibitor 3HOI-BA-01 Protect Cardiomyocytes After Ischemia Through Induction of Autophagy. J Cardiovasc Pharmacol Ther. 2016 Jan;21(1):70-8[1]doi: 10.1177/1074248415581177. Epub 2015 Apr 13. PubMed PMID: 25868658. |
| [2]Xie H, Lee MH, Zhu F, Reddy K, Huang Z, Kim DJ, Li Y, Peng C, Lim DY, Kang S, Jung SK, Li X, Li H, Ma W, Lubet RA, Ding J, Bode AM, Dong Z. Discovery of the novel mTOR inhibitor and its antitumor activities in vitro and in vivo. Mol Cancer Ther. 2013 Jun;12(6):950-8. doi: 10.1158/1535-7163.MCT-12-1241. Epub 2013 Mar 27. PubMed PMID: 23536724; PubMed Central PMCID: PMC3681861. |
对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
- 相关产品
-
< >
- 推荐产品
-
< >
- 最新产品
-
< >
新闻
抱歉,暂无数据!


购物车 


